Yes, it's still hard for dads to talk ab...

Yes, it's still hard for dads to talk about condoms with sons


(Reuters Health) - - Many boys want their fathers to be the ones to talk to them about condoms. But a new study offers fresh evidence of all the ways these conversations can be complicated and leave young men without a clear picture of how to have safe sex.

Friday report cards tied to higher risk of child abuse

(Reuters Health) - - Kids who bring home report cards on Fridays may be more likely to experience child abuse afterward than kids who get their grades on other days, a U.S. study suggests.

Read more


Study finds antibiotic-resistant bacteria in Brazil pork

Pork products sold at retailers in Brazil contain antibiotic-resistant bacteria, according to a study funded by animal rights group World Animal Protection (WAP), providing potential evidence of overuse of the medicines in food livestock.

Read more


One in four U.S. parents unprepared for holiday hangover

(Reuters Health) - - While most parents heading out for alcohol-infused holiday parties will have arranged for child care while they're out and for transportation back home in case they become tipsy, one in four won't have put much thought into how they'll handle the kids if they have a hangover the next morning, a U.S. survey suggests.

Read more


Evofem shares surge as contraceptive gel meets late-stage trial goal

Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel showed effectiveness in a late-stage study, bringing the first hormone-free contraceptive close to approval.

Read more


E-cigarette usage nearly doubles in U.S. high-schools: survey

The percentage of high school seniors who used e-cigarettes in the last 30 days nearly doubled to 20.9 percent from last year, results of a survey released by the National Institute on Drug Abuse showed on Monday.

Read more


BrainStorm gets FDA okay for stem cell trial in MS patients

BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin a clinical trial of its experimental stem cell treatment in patients with progressive multiple sclerosis.

Read more


Trump hails judge's ruling against Obamacare as 'great'

President Donald Trump on Saturday hailed a court decision against Obamacare as "a great ruling for our country," while a U.S. government official said the decision by a Texas judge would have no immediate impact on health coverage.

Read more


Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial

Eli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found to be more effective than the world's best-selling prescription medicine, AbbVie Inc's Humira, in a late-stage trial.

Read more


Nicox teams up with Chinese firm to develop and sell glaucoma drug

French ophthalmology company Nicox and Chinese firm Ocumension Therapeutics said on Monday they had signed an exclusive license agreement to develop and sell a yet-to-be approved Nicox drug to treat glaucoma in China.

Read more


China confirms new African swine fever cases in Sichuan, Heilongjiang

China confirmed two new cases of African swine fever, as the disease continues to spread through the world's largest hog herd, the Ministry of Agriculture and Rural Affairs said late on Sunday in a statement on its website.

Read more


Study finds chronic fatigue clues in overactive immune response

Scientists exploring what may trigger a complex disorder known as chronic fatigue syndrome (CFS) have found clues in the way some people's immune systems respond more actively to a health attack.

Read more


Special Report: J&J knew for decades that asbestos lurked in its Baby Powder

Darlene Coker knew she was dying. She just wanted to know why.

Read more


J&J kept a guiding hand on talc safety research

Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

Read more


J&J shares nosedive on report it knew of asbestos in Baby Powder

Shares of Johnson & Johnson fell 10 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Powder.

Read more


Flu shots tied to lower risk of premature death with heart failure

(Reuters Health) - - People with heart failure who get flu shots may be less likely to die prematurely than their counterparts who don't get vaccinated, a Danish study suggests.

Read more


Menopause-related sexual, urinary problems tied to worse quality of life

(Reuters Health) - - Severe sexual and urinary health problems after menopause are linked with poorer quality of life, a recent study suggests.

Read more


Worth the sting: Cuba's scorpion pain remedy

Once a month for the last decade, Pepe Casanas, a 78-year-old Cuban farmer, has hunted down a scorpion to sting himself with, vowing that the venom wards off his rheumatism pains.

Read more


Pfizer's cut-price version of Avastin wins EU panel greenlight

A panel of European Medicines Agency (EMA) on Friday recommended approval for Pfizer Inc's Zirabev, a cheaper version to Roche Holding AG's leading cancer drug Avastin.

Read more


Doctors struggle to help older gun owners

(Reuters Health) - Doctors who work with seniors are grappling with ways to prevent gun-related suicides and accidents, often among gun-owning older patients with dementia or depression, according to a recent review article.

Read more